The following is a summary of “Efficacy and safety of topical minocycline preparations for papulopustular rosacea: a systematic review and meta-analysis,” published in the April 2025 issue of ...
Rosacea, a chronic skin condition causing redness and visible blood vessels on the face, has been associated with liver ...
A new study reveals that combining rhinoshave with fractional ablative CO2 laser therapy offers precise, long-lasting results ...
Dr. Towery from the US Dermatology Partners joined Samantha in the studio this morning to share how the chronic skin disease Rosacea plagues many Americans. Dr. Towery also shares what causes the ...
Patients with rosacea experienced improvement with Emrosi, an oral minocycline hydrochloride extended-release product, ...
Rosacea is a common skin condition in here Ireland and your skincare routine can both aggravate and lessen the symptoms of ...
Many products fail to address the root causes of redness. Revoderm Pharma takes a science-backed, dermatologist-developed ...
Protect Without Irritation If you have rosacea or sensitive skin, you already know how challenging it can be to find a sunscreen that ...
Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ...
New antibiotic has been approved for uncomplicated UTIs; Cabometyx approved for advanced neuroendocrine tumors; new rosacea treatment option; Tremfya ...
Emrosi (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results